Research Article
The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma
Table 2
The statistical analysis of the levels of serum markers between HCC group and non-HCC group.
| | Markers | HCC group | Non-HCC group | values | values | | Statistical description | | Statistical description |
| | ALB (g/L) | 34 | | 75 | | 0.897 | 0.542 | | TBIL (μmol/L) | 34 | 24.85 (4.8–385.6) | 75 | 24.1 (6.5–109) | −0.618 | 0.536 | | ALT (IU/L) | 34 | 52 (20–254) | 75 | 35 (9–416) | −3.212 | 0.001 | | PLT (109/L) | 34 | 70.5 (29–165) | 75 | 62 (23–599) | −0.981 | 0.326 | | Pt(s) (s) | 34 | 13.5 (10.5–21.6) | 75 | 14.00 (9.7–21.4) | −1.237 | 0.216 | | Pt(a) (%) | 34 | | 75 | | 1.313 | 0.507 | | AFP (ng/mL) | 34 | 30.88 (1.41–1432) | 75 | 5.62 (0.9–617.4) | −3.944 | 0.000 | | GP73 (ng/mL) | 34 | 212.6 (66.12–350) | 75 | 202.8 (65.38–391.9) | −0.654 | 0.513 | | AFP-L3 (ng/mL) | 34 | 2.09 (0.07–77.45) | 75 | 0.273 (0.05–34.4) | −4.068 | 0.000 | | AFP-L3/AFP ratio | 34 | 0.051 (0.03–0.43) | 75 | 0.05 (0.02–0.12) | −2.019 | 0.043 |
|
|
Normally distributed data were reported as . Other data were reported as median (minimum, maximum); : number of samples.
|
